Gabapentin in the management of pentazocine dependence: A potent analgesic - Anticraving agent

Journal of Association of Physicians of India

Volumn 51, Issue JUL, 2003, Pages 673-676

  Kumar, P ^a   Jain, M K ^a  

^a SS Med Coll   (India)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ACETIC ACID DERIVATIVE; AMINE; ANALGESIC AGENT; ANXIOLYTIC AGENT; CLONIDINE; CYCLOHEXANECARBOXYLIC ACID DERIVATIVE; GABAPENTIN; NARCOTIC ANALGESIC AGENT; PENTAZOCINE;

ADDICTION; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COMBINATION; FEMALE; HUMAN; MALE; PAIN; PSYCHOLOGICAL ASPECT; WITHDRAWAL SYNDROME;

ACETIC ACIDS; AMINES; ANALGESICS; ANALGESICS, OPIOID; ANTI-ANXIETY AGENTS; CLONIDINE; CYCLOHEXANECARBOXYLIC ACIDS; DRUG THERAPY, COMBINATION; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; PAIN; PENTAZOCINE; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANCE-RELATED DISORDERS;

EID: 2842532759     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Gold ME, Redmond DC, Kleber HD. Clonidine blocks acute opiate withdrawal symptoms. Lancet 1978;2:599-602.
2. Kleber HD, Topazian M, Gaspari J, Ribordan CE, Kosten T. Clonidine and Naltrexone in the out-patient treatment of heroin withdrawal. Am J Drug Alcohol Abuse 1982;13:1.
3. Jaffe JH. Opioid related disorder: In Comprehended Textbook of Psychiatry. Vol. I, 1st Ed. p. 856, Harold/ Kaplan and Benjamin J, Sadock, Williams and Wilkins USA, 1995.
4. Malzack R: Gate-Control theory. Pain Forum 1996;5:128-38.
5. Ramdell, LO, Selitto JJ. A method for measurement of analgesic activity on inflamed tissue. Arch Int Pharmacodyn Ther 1957;111:409-19.
6. Nicholson B. Gabapentin use in neuropathic pain syndromes. Acta Neurol Scand 2000;101:359-71.
7. Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus ML. Gabapentin for the treatment of postherpetic neuralgia: A randomised controlled trial. JAMA 1998;280: 1837-42.
8. Gascia-Callejo FJ, Velert-Vile MM, Talamantes-Escripa F, Blay-Galand L. Clinical response of Gabapentin for glossopharyngeal neuralgia. Rev Neurol 1999;28:380-4.
9. Myrick H, Henderson S, Brady KT, Malcoln R. Gabapentin in the treatment of cocaine dependence: A case series. J Clin Psychiatry 2001;62:1,19-23.
10. Myrick H, Malcom R, Brady K. Gabapentin treatment of alcohol withdrawal. Am J Psychiatry 1998;155:1632.
11. DSM IV-TR: Diagnostic and statistical manual or mental disorder. Text Revision, American Psychiatric Association, Washington, 2000.
12. Revill SI, Robinson JO, Rosen M, Hogg MI. The reliability of a linear analogue for evaluating pain. Anaesthesia 1976;31:1191.
13. Dixit KS, Kumar P, Saxena RC, Bhargava KP, Saxena VS. A double blind comparison of the analgesic efficacy of soluble aspirin, plain aspirin and placebo. Acta Therapeutica 1984;10:333-40.
14. Pelc I, Verbanck P, Le Ban O, Gavrtlovic M, Lion K, Lehert P. Efficacy and safety of Acomprosate in the treatment of detoxified alcohol dependent patients. A 90 day placebocontrolled dose finding study. Brit J Psychiatry 1997;17:73-7.
15. Loimer N, Linzmayer L, Schimid R, Gruinberger J. Similar efficacy of abrupt and gradual opiate detoxification. Am J Drug Alcohol Abuse 1991;17:307.
16. Paalzov G: Development of tolerance to the analgesic effect of Clonidine in rats. Cross-tolerance to morphine. Naunyn Schimiedebergs Arch Pharmacol 1978;304:1-4.
17. Caraceni A, Zecca E, Martini C, De Conno F. Gabapentin as an adjuvant to opioid analgesia for neuropathic cancer pain. Pain symptom manage 1999;17:441-5.
18. Schaffer CB, Schaffer LC. Gabapentin in the treatment of bipolar disorder (letter). Am J Psychiatry 1997;154;291-2.
19. Pollack MH, Matthews J, Scott EL. Gabapentin as a potential treatment for anxiety disorder (letter). Am J Psychiatry 1998;155:992-3.
20. Ryback R, Ryback L. Gabapentin for behavioural dyscontrol (letter). Am J Psychiatry 1995;152:1398.